Loading...
Pharmagreen Biotech Inc.
PHBI•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.001
$0.00(10.00%)
Pharmagreen Biotech Inc. (PHBI) Financial Performance & Statements
Review Pharmagreen Biotech Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
13.74%
↑ 13.74%
Operating Income Growth
47.64%
↑ 47.64%
Net Income Growth
-76.59%
↓ 76.59%
Operating Cash Flow Growth
61.96%
↑ 61.96%
Operating Margin
-7807.79%
↓ 7807.79%
Gross Margin
44.84%
↑ 44.84%
Net Profit Margin
-7536.88%
↓ 7536.88%
ROE
9.06%
↑ 9.06%
ROIC
10.15%
↑ 10.15%
Pharmagreen Biotech Inc. (PHBI) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Pharmagreen Biotech Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $828.00 | $501.00 | $615.00 | $1058.00 |
| Cost of Revenue | $459.00 | $375.00 | $482.00 | $340.00 |
| Gross Profit | $369.00 | $126.00 | $133.00 | $718.00 |
| Gross Profit Ratio | $0.45 | $0.25 | $0.22 | $0.68 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $61808.00 | $50488.00 | $57200.00 | $66237.00 |
| Operating Expenses | $61808.00 | $50488.00 | $57200.00 | $66237.00 |
| Total Costs & Expenses | $62267.00 | $50863.00 | $57682.00 | $66577.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $7980.00 | $8460.00 |
| Depreciation & Amortization | $61439.00 | $50362.00 | $22498.00 | $65518.00 |
| EBITDA | $0.00 | $0.00 | -$34572.00 | $27563.00 |
| EBITDA Ratio | $0.00 | $0.00 | -$56.21 | $26.05 |
| Operating Income | -$61439.00 | -$50362.00 | -$57070.00 | -$65519.00 |
| Operating Income Ratio | -$74.20 | -$100.52 | -$92.80 | -$61.93 |
| Other Income/Expenses (Net) | $694728.00 | -$728709.00 | $14515.00 | $27564.00 |
| Income Before Tax | $633289.00 | -$779071.00 | -$42555.00 | -$37955.00 |
| Income Before Tax Ratio | $764.84 | -$1555.03 | -$69.20 | -$35.87 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$65518.00 |
| Net Income | $633289.00 | -$779071.00 | -$42520.00 | -$37955.00 |
| Net Income Ratio | $764.84 | -$1555.03 | -$69.14 | -$35.87 |
| EPS | $0.001 | -$0.001 | -$0.00 | -$0.00 |
| Diluted EPS | $0.001 | -$0.001 | -$0.00 | -$0.00 |
| Weighted Avg Shares Outstanding | $663.65M | $664.17M | $663.65M | $663.65M |
| Weighted Avg Shares Outstanding (Diluted) | $663.65M | $663.68M | $663.65M | $663.65M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan